These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25306889)

  • 1. Recombinant murine fibroblast growth factor 21 ameliorates obesity-related inflammation in monosodium glutamate-induced obesity rats.
    Wang WF; Li SM; Ren GP; Zheng W; Lu YJ; Yu YH; Xu WJ; Li TH; Zhou LH; Liu Y; Li DS
    Endocrine; 2015 May; 49(1):119-29. PubMed ID: 25306889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome.
    Sasaki Y; Shimada T; Iizuka S; Suzuki W; Makihara H; Teraoka R; Tsuneyama K; Hokao R; Aburada M
    Eur J Pharmacol; 2011 Jul; 662(1-3):1-8. PubMed ID: 21549692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
    Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
    Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic effect of fibroblast growth factor 21 on NAFLD in MSG-iR mice and its mechanism].
    Zhu SL; Zhang ZY; Ren GP; Ye XL; Ma L; Yu D; Han MM; Zhao JZ; Zhang TY; Li DS
    Yao Xue Xue Bao; 2013 Dec; 48(12):1778-84. PubMed ID: 24689234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monosodium glutamate neonatal intoxication associated with obesity in adult stage is characterized by chronic inflammation and increased mRNA expression of peroxisome proliferator-activated receptors in mice.
    Roman-Ramos R; Almanza-Perez JC; Garcia-Macedo R; Blancas-Flores G; Fortis-Barrera A; Jasso EI; Garcia-Lorenzana M; Campos-Sepulveda AE; Cruz M; Alarcon-Aguilar FJ
    Basic Clin Pharmacol Toxicol; 2011 Jun; 108(6):406-13. PubMed ID: 21205225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperine ameliorates insulin resistance via inhibiting metabolic inflammation in monosodium glutamate-treated obese mice.
    Liu C; Yuan Y; Zhou J; Hu R; Ji L; Jiang G
    BMC Endocr Disord; 2020 Oct; 20(1):152. PubMed ID: 33028294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast Growth Factor 21 (FGF21) Administration Sex-Specifically Affects Blood Insulin Levels and Liver Steatosis in Obese
    Makarova E; Kazantseva A; Dubinina A; Denisova E; Jakovleva T; Balybina N; Bgatova N; Baranov K; Bazhan N
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin Prevents Fatty Liver and Improves Balance of White/Brown Adipose in an Obesity Mouse Model by Inducing FGF21.
    Kim EK; Lee SH; Jhun JY; Byun JK; Jeong JH; Lee SY; Kim JK; Choi JY; Cho ML
    Mediators Inflamm; 2016; 2016():5813030. PubMed ID: 27057099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional effect of metformin and celecoxib against lipid dysregulation and adipose tissue inflammation in high-fat fed rats with insulin resistance and fatty liver.
    Lu CH; Hung YJ; Hsieh PS
    Eur J Pharmacol; 2016 Oct; 789():60-67. PubMed ID: 27397427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Food deprivation-induced changes in body fat mobilization after neonatal monosodium glutamate treatment.
    Leitner C; Bartness TJ
    Am J Physiol Regul Integr Comp Physiol; 2008 Mar; 294(3):R775-83. PubMed ID: 18094070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
    Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
    Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice.
    Yamazaki Y; Usui I; Kanatani Y; Matsuya Y; Tsuneyama K; Fujisaka S; Bukhari A; Suzuki H; Senda S; Imanishi S; Hirata K; Ishiki M; Hayashi R; Urakaze M; Nemoto H; Kobayashi M; Tobe K
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1179-86. PubMed ID: 19724016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PGC-1α may associated with the anti-obesity effect of taurine on rats induced by arcuate nucleus lesion.
    Cao PJ; Jin YJ; Li ME; Zhou R; Yang MZ
    Nutr Neurosci; 2016; 19(2):86-93. PubMed ID: 25211138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy.
    Zhu S; Wu Y; Ye X; Ma L; Qi J; Yu D; Wei Y; Lin G; Ren G; Li D
    Mol Cell Biochem; 2016 Sep; 420(1-2):107-19. PubMed ID: 27435856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of CB1 receptor blockade on monosodium glutamate induced hypometabolic and hypothalamic obesity in rats.
    Chen W; Chen Z; Xue N; Zheng Z; Li S; Wang L
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):721-32. PubMed ID: 23620336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taurine prevents fat deposition and ameliorates plasma lipid profile in monosodium glutamate-obese rats.
    Nardelli TR; Ribeiro RA; Balbo SL; Vanzela EC; Carneiro EM; Boschero AC; Bonfleur ML
    Amino Acids; 2011 Oct; 41(4):901-8. PubMed ID: 21042817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin improves insulin sensitivity in mice with obesity induced by monosodium glutamate.
    Zhang N; Huan Y; Huang H; Song GM; Sun SJ; Shen ZF
    Acta Pharmacol Sin; 2010 Jan; 31(1):35-42. PubMed ID: 20023693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal monosodium glutamate treatment causes obesity, diabetes, and macrovesicular steatohepatitis with liver nodules in DIAR mice.
    Tsuneyama K; Nishida T; Baba H; Taira S; Fujimoto M; Nomoto K; Hayashi S; Miwa S; Nakajima T; Sutoh M; Oda E; Hokao R; Imura J
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1736-43. PubMed ID: 24730643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hepatoprotective effect of the combination use of Fructus Schisandrae with statin--A preclinical evaluation.
    Wat E; Ng CF; Wong EC; Koon CM; Lau CP; Cheung DW; Fung KP; Lau CB; Leung PC
    J Ethnopharmacol; 2016 Feb; 178():104-14. PubMed ID: 26666731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease.
    Collison KS; Maqbool Z; Saleh SM; Inglis A; Makhoul NJ; Bakheet R; Al-Johi M; Al-Rabiah R; Zaidi MZ; Al-Mohanna FA
    J Lipid Res; 2009 Aug; 50(8):1521-37. PubMed ID: 19001666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.